Literature DB >> 503493

Benign chondroblastoma of the temporal bone.

S G Harner, D T Cody, D C Dahlin.   

Abstract

Benign chondroblastoma is a rare tumor in the temporal bone. It occurs preponderantly in middle-aged men as a mass in the postero-superior region of the ear canal and is accompanied by hearing loss. On pathologic examination, giant cells and focal regions of chondroid differentiation are noted. After the extent of the tumor has been determined, the treatment is surgical removal. Preoperative irradiation may be helpful. Long-term follow-up is essential.

Entities:  

Mesh:

Year:  1979        PMID: 503493     DOI: 10.1177/019459987908700213

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg (1979)


  6 in total

1.  Chondroblastoma of the temporal bone: consistent middle fossa involvement.

Authors:  S H Selesnick; J M Levine
Journal:  Skull Base Surg       Date:  1999

2.  Chondroblastoma of temporal bone.

Authors:  K Tanohata; M Noda; H Katoh; A Okazaki; S Sugiyama; S Onishi; T Tanida; T Maehara
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

3.  Chondroblastoma: a clinical and radiological study of 104 cases.

Authors:  J L Bloem; J D Mulder
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

4.  Successful function-preserving therapy for chondroblastoma of the temporal bone involving the temporomandibular joint.

Authors:  Junkichi Yokoyama; Hitoshi Yoshimoto; Shin Ito; Shinichi Ohba; Mitsuhisa Fujimaki; Katsuhisa Ikeda; Masaki Yazawa; Nozomi Fujimiya; Makoto Hanaguri
Journal:  Case Rep Oncol       Date:  2011-02-14

5.  Chondroblastoma of the Clivus: Case Report and Review.

Authors:  Jonathan Liu; Arjang Ahmadpour; Arnaud F Bewley; Mirna Lechpammer; Matthew Bobinski; Kiarash Shahlaie
Journal:  J Neurol Surg Rep       Date:  2015-10-09

6.  Chondroblastoma of the temporal bone: a case series, review, and suggested management strategy.

Authors:  Luke B Reid; David S Wong; Bernard Lyons
Journal:  Skull Base Rep       Date:  2011-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.